Advent International to buy majority stake in Bharat Serums and Vaccines

Private equity firm Advent International (Advent) has signed a definitive agreement to acquire a majority interest in Bharat Serums and Vaccines Limited for an undisclosed sum. Bharat Serums is a biopharmaceutical player in women’s healthcare, assisted reproductive treatment, critical care and emergency medicine in India and emerging markets.

OrbiMed PE and Kotak PE, two private equity firms that previously held minority positions in Bharat Serums, will fully exit their investments in the company. The Daftary family, which founded Bharat Serums, is retaining a meaningful equity stake and is partnering with Advent on the company’s next stage of growth, Advent said